# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Mucopolysaccharidosis type II

Hunter Syndrome
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 16 results.
RGX-121 Gene Therapy in Patients With MPS II (Hunter Syndrome)
Status: Recruiting
Last Changed: Jun 03, 2019
First Received: Jun 21, 2018
Disease(s): Mucopolysaccharidosis Type II (MPS II)
Intervention(s): RGX-121
Locations: Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders, Pittsburgh, Pennsylvania, United States
A Study of Potential Treatment-Responsive Biomarkers in Hunter Syndrome
Status: Not yet recruiting
Last Changed: Jul 03, 2019
First Received: Jul 03, 2019
Disease(s): Hunter Syndrome
Intervention(s): No Intervention
The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients
Status: Recruiting
Last Changed: Jun 20, 2014
First Received: Jan 24, 2014
Disease(s): Hunter Syndrome
Locations: Samsung Medical Center, Seoul, Korea, Republic of
Study of Idursulfase-beta (GC1111) in Hunter Syndrome
Status: Not yet recruiting
Last Changed: Jan 26, 2016
First Received: Jan 26, 2016
Disease(s): Mucopolysaccharidosis II
Intervention(s): idursulfase beta, idursulfase
Hunter Outcome Survey (HOS)
Status: Recruiting
Last Changed: Mar 19, 2019
First Received: Sep 26, 2017
Disease(s): Hunter Syndrome
Locations: Shire, Lexington, Massachusetts, United States
A Study of GC1111 in Hunter Syndrom Patients
Status: Recruiting
Last Changed: Apr 24, 2019
First Received: Apr 19, 2019
Disease(s): Hunter Syndrome
Intervention(s): GC1111, Comparator
Locations: Samsug Medical Center, Seoul, Korea, Republic of
Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)
Status: Recruiting
Last Changed: May 09, 2019
First Received: Jul 11, 2018
Disease(s): Hunter Syndrome
Locations: Hospital Pediátrico de Sinaloa, Culiacán Rosales, México, Mexico
IMSS UMAE 25 (INSTITUTO MEXICANO DEL SEGURO SOCIAL UNIDAD MEDICA DE ALTA ESPECIALIDAD No 25), Monterrey, Nuevo León, Mexico
Hospital del Niño Tabasqueño, Villahermosa, Tabasco, Mexico
Hospital Centenario Miguel Hidalgo, Aguascalientes, Mexico
Hospital Infantil Federico Gomez, Ciudad de México, Mexico
... and 2 other locations.
Biomarker for Hunter Disease (BioHunter)
Status: Recruiting
Last Changed: Jul 10, 2019
First Received: Apr 06, 2011
Disease(s): Inguinal Hernia, Tonic-clonic, Glaucoma
Locations: Children Hospital, Faculty of Medicine, Cairo University, Cairo, Egypt
Ain Shams University, El Cairo, Egypt
Amrita Institute of Medical Sciences, Kerola, India
Navi Mumbai Institute of Research In Mental And Neurological Handicap (NIRMAN), Mumbai, India
Centenario Hospital Miguel Hidalgo, Aguascalientes, Mexico
... and 5 other locations.
Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I and II
Status: Recruiting
Last Changed: Jul 02, 2019
First Received: May 15, 2017
Disease(s): Mucopolysaccharidosis I, Mucopolysaccharidosis II
Intervention(s): Adalimumab Injection [Humira], Saline Solution for Injection
Locations: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
Status: Recruiting
Last Changed: Jun 07, 2019
First Received: Oct 02, 2014
Disease(s): Adrenoleukodystrophy, Batten Disease, Mucopolysaccharidosis II, Leukodystrophy, Globoid Cell, Leukodystrophy, Metachromatic, Neimann Pick Disease, Pelizaeus-Merzbacher Disease, Sandhoff Disease, Tay-Sachs Disease, Brain Diseases, Metabolic, Inborn, Alpha-Mannosidosis, Sanfilippo Mucopolysaccharidoses
Intervention(s): DUOC-01
Locations: Duke University Medical Center, Durham, North Carolina, United States